Development and routine tissue homeostasis require a high turnover of apoptotic cells. These cells are removed by professional and non-professional phagocytes via efferocytosis 1 . How a phagocyte maintains its homeostasis while coordinating corpse uptake, processing ingested materials and secreting antiinflammatory mediators is incompletely understood 1, 2 . Here, using RNA sequencing to characterize the transcriptional program of phagocytes actively engulfing apoptotic cells, we identify a genetic signature involving 33 members of the solute carrier (SLC) family of membrane transport proteins, in which expression is specifically modulated during efferocytosis, but not during antibody-mediated phagocytosis. We assessed the functional relevance of these SLCs in efferocytic phagocytes and observed a robust induction of an aerobic glycolysis program, initiated by SLC2A1-mediated glucose uptake, with concurrent suppression of the oxidative phosphorylation program. The different steps of phagocytosis 2 -that is, 'smell' ('find-me' signals or sensing factors released by apoptotic cells), 'taste' (phagocyte-apoptotic cell contact) and 'ingestion' (corpse internalization)-activated distinct and overlapping sets of genes, including several SLC genes, to promote glycolysis. SLC16A1 was upregulated after corpse uptake, increasing the release of lactate, a natural by-product of aerobic glycolysis 3 . Whereas glycolysis within phagocytes contributed to actin polymerization and the continued uptake of corpses, lactate released via SLC16A1 promoted the establishment of an anti-inflammatory tissue environment. Collectively, these data reveal a SLC program that is activated during efferocytosis, identify a previously unknown reliance on aerobic glycolysis during apoptotic cell uptake and show that glycolytic byproducts of efferocytosis can influence surrounding cells.
. Mutations in approximately 100 of the 400 known SLCs are linked to human disease [6] [7] [8] . In LR73 phagocytes, expression levels of 33 SLCs (out of 165 detected) were modified during efferocytosis: 19 were upregulated and 14 were downregulated (Extended Data Fig. 2 , Supplementary Table 2) .
We categorized the 33 SLCs on the basis of association with physiological processes, experimentally or by homology (Extended Data Fig. 2b ), and constructed an integrated network linking each SLC and its assigned functions with other SLCs modified during efferocytosis (Fig. 1b) . All but two SLCs (Slc6a4 and Slc45a4) could be clustered into eight categories: carbohydrate metabolism; intracellular pH regulation; membrane stability and volume regulation; nucleoside salvage; vitamin transport; glycosylation; amino acid transport and catabolism; and OXPHOS and FAO. This analysis also reveals coordinated regulation of SLCs linked to particular physiological function(s): multiple SLCs associated with carbohydrate metabolism were upregulated, whereas SLCs associated with OXPHOS and FAO were downregulated (Fig. 1b) . The changes in SLC expression were confirmed by quantitative reverse transcription with PCR (qRT-PCR) using hamster-specific primers (Extended Data Fig. 3a, b) . Thus, efferocytosis induces a specific SLC signature that potentially modulates multiple physiological processes.
Mouse peritoneal macrophages displayed similar modulation of SLCs during efferocytosis, suggesting that professional and nonprofessional phagocytes shared a similar response ( Table 3) . Notably, macrophages ingesting Jurkat cells coated with CD3 antibody (with comparable phagocytosis), did not show changes in the same SLCs, except for Slc29a2 and Slc29a3, which responded in the opposite direction to the efferocytosis response (Fig. 2a) . Thus, in addition to the type of engulfed cell, the type of phagocytic receptor used influences the SLC program in phagocytes. Furthermore, when apoptotic Jurkat cells were injected intraperitoneally into mice, efferocytic CD11b high F4/80 high macrophages exhibited similar changes in SLC gene expression to those seen in the in vitro efferocytosis (Fig. 2b) .
In a time course of efferocytosis, expression of several SLCs was modulated early (0-4 h), whereas others were upregulated later (after 4 h). Even within a group of SLCs linked to a particular function, we observed early and late modulation of expression. These changes were not strict, and mRNA and protein concentrations exhibited continuous variation through the time course (Extended Data Fig. 4) .
Distinct stages or phases in efferocytosis have been identified 1,2 , including (i) smell phase, in which apoptotic cells and phagocytes communicate via soluble mediators; (ii) taste phase, in which ligandreceptor interactions are established between apoptotic cells and phagocytes; and (iii) ingestion phase, in which corpses are internalized and processed. To identify SLCs that are modulated during the different stages of efferocytosis, we performed and compared RNA-seq analyses Letter reSeArCH of LR73 cells treated only with apoptotic cell supernatants with those of phagocytosing LR73 cells treated with cytochalasin D, which allows corpse binding but not internalization (Fig. 2c ). These data, using SLC induction as a readout, provide further evidence for ongoing communication between apoptotic cells and phagocytes.
Efferocytosis is an energy-intensive process, as it requires energy for dynamic actin rearrangements to engulf corpses that are often nearly as large as the phagocyte 9 . We focused on SLC2A1 (also known as GLUT1), a glucose transporter that facilitates uptake of glucose from the extracellular medium 10 , as SLC2A1 was strongly upregulated in LR73 cells and macrophages early during efferocytosis (Fig. 2, Extended Data Fig. 4b ). First, overexpressing SLC2A1 in LR73 cells increased efferocytosis (Fig. 3a) . Second, treatment with STF-31, an inhibitor of SLC2A1, reduced efferocytosis in wild-type and SLC2A1-overexpressing LR73 cells (Fig. 3a) . Third, small interfering RNA (siRNA) knockdown of Slc2a1 reduced corpse uptake (Fig. 3b) ; this effect was rescued by co-transfection with siRNA-resistant Slc2a1 (Fig. 3b) . Fourth, CRISPR-Cas9 deletion of Slc2a1 reduced efferocytosis in LR73 cells (Fig. 3c) . Fifth, Slc2a1-deficient bone-marrow-derived macrophages (BMDMs) displayed decreased efferocytosis (Fig. 3d) , but retained normal antibody-mediated phagocytosis (which does not modulate Slc2a1 expression) compared to untreated cells (Extended Data Fig. 5a ). Deletion efficiencies for Slc2a1 are shown in Extended Data Fig. 5b-d .
In vivo administration of STF-31 11 before intraperitoneal injection of apoptotic Jurkat cells decreased efferocytosis by peritoneal macrophages (Fig. 3e) , but not phagocytosis of CD3-antibody-coated Jurkat cells (Extended Data Fig. 5e ). Moreover, STF-31 did not further reduce efferocytosis in Slc2a1-deficient LR73 cells or BMDMs (Extended Data Fig. 5f ), indicating that the effects were specific to SLC2A1. We also tested corpse clearance in the thymus after induction of apoptosis by dexamethasone injection 12 , with or without co-injection of STF-31. There was a modest increase in uncleared or secondarily necrotic thymocytes in response to STF-31 alone, and a significant increase in necrotic thymocytes in response to treatment with both dexamethasone and STF-31 (Fig. 3f, Extended Data Fig. 5g) .
To complement the pharmacological approach, we used two genetic approaches. First, using zebrafish expressing GFP in macrophages (Tg(mpeg1:GFP)), we targeted the Slc2a1 orthologue via morpholino oligonucleotide injection 13 . In control morpholino-treated embryos, GFP + macrophages exhibited numerous phagocytic puncta (containing and/or associated with neutral red), whereas slc2a1a morphant embryos had fewer such associations (Fig. 3g) . Quantifying z-stack images, and focusing on macrophages in the trunk region, slc2a1a morphants displayed fewer neutral red + macrophages and less neutral-red staining per macrophage (Fig. 3g) . This also suggested an evolutionarily conserved role for SLC2A1. Second, we tested the Slc2a1 requirement in a mouse model of atherosclerosis, in which defective apoptotic cell clearance can manifest as increased necrotic cores within plaques 1, 14 . Bone marrow transplantation was performed with cells from myeloid-targeted LysM-Cre Slc2a1 fl/fl mice (myeloid differentiation was not affected) into atherosclerosis-prone Ldlr −/− mice. After Western diet feeding (12 weeks), there was a significant increase of the necrotic core area in the aortic roots of mice deficient in Slc2a1 in the myeloid lineage (Fig. 3h) . The number of TUNEL-positive nuclei (late apoptotic cells) also significantly increased within necrotic cores, implicating defective corpse clearance (Fig. 3h) . Taken together, these results show that SLC2A1 contributes to engulfment of apoptotic cells both in vitro and in vivo.
As SLC2A1 is a glucose transporter 8, 10 , we investigated whether glucose uptake is important for efferocytosis. Switching LR73 cells to glucose-free medium at the initiation of efferocytosis reduced uptake of apoptotic cells (Fig. 4a) ; conversely, adding exogenous glucose increased uptake of apoptotic cells (Fig. 4a) , a phenotype that was attenuated by silencing Slc2a1 (Extended Data Fig. 6a ). We also measured glucose uptake directly using the non-metabolizable glucose analogue 2-deoxyglucose (2-DG); 2-DG uptake increased approximately threefold during efferocytosis (Fig. 4b) . Further, phagocytes pre-treated with 2-DG showed decreased efferocytosis (Extended Data Fig. 6b ). Thus, SLC2A1-mediated glucose uptake is an important step in efferocytosis.
Seahorse analysis of LR73 phagocytes (Fig. 4c) or BMDMs (Extended Data Fig. 6c ) showed increased aerobic glycolysis and decreased OXPHOS in engulfing phagocytes (Fig. 4c) . Analysis of the RNA-seq data from engulfing phagocytes (Fig. 1a) revealed upregulation of multiple glycolysis genes (Fig. 4d, Extended Data Fig. 6d) , with concurrent downregulation of OXPHOS and FAO genes. siRNA-mediated knockdown of PDK1 (Fig. 4e) or PDK4 (Fig. 4f) , which promote aerobic glycolysis 15 , or treatment with the pan-PDK inhibitor dichloroacetate (Fig. 4g) , resulted in decreased efferocytosis. Notably, when we compared BMDMs treated with dichloroacetate to block aerobic glycolysis with BMDMs treated with rotenone and antimycin A1 to block OXPHOS, we found that PDK inhibition reduced efferocytosis but not antibody-mediated phagocytosis, whereas OXPHOS inhibition reduced antibody-mediated phagocytosis, but not efferocytosis (Extended Data  Fig. 7a ).
Phosphorylation of SLC2A1 by SGK1 increases the abundance of SLC2A1 at the plasma membrane 16 . Sgk1 mRNA was upregulated during efferocytosis (Fig. 4d, Extended Data Fig. 6d) , and targeting SGK1 
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with siRNA or the SGK1 inhibitor GSK650394 decreased uptake of apoptotic cells (Fig. 4h, Extended Data Fig. 7b ). Further, efferocytic BMDMs from transgenic mice expressing an extracellular Myc tag on SLC2A1 10 exhibited increased cell-surface expression of Myc-SLC2A1; this effect was also inhibited by GSK650394 (Extended Data Fig. 7c ).
Phagocytes frequently ingest multiple apoptotic corpses sequentially 12 . To address whether SLC2A1 is required for the uptake of the first corpse, or for continued uptake of further corpses, we treated phagocytes with inhibitors for SLC2A1 or SGK1 at different times during efferocytosis. SLC2A1 function was required for uptake of the first corpse as well as for continued uptake of additional corpses (Extended Data Fig. 7d ).
Corpse internalization requires substantial actin polymerization, which has been linked to aerobic glycolysis during cell migration 1, 9 . Increased actin polymerization in efferocytic phagocytes (indicated by phalloidin staining) was inhibited by treatment with either STF-31 or 2-DG (Fig. 4i) . Inhibiting PDK1, which favours aerobic glycolysis, also reduced F-actin formation (Fig. 4i) . Thus, SLC2A1-mediated glucose uptake and glucose utilization in aerobic glycolysis contribute to actin polymerization during efferocytosis.
Distinct steps of SLC2A1-dependent aerobic glycolysis in phagocytes were regulated by the smell, taste and ingestion phases of efferocytosis (Fig. 5a-c) . Apoptotic supernatant was sufficient to increase Sgk1 expression, but not that of Slc2a1 (Fig. 5a ). ATP (a known find-me signal) 17 also increased Sgk1 expression (Extended Data Fig. 8a ). Similarly, high fraction by qRT-PCR using mouse-specific primers (right). In b, right panel, the grey bar for Slc29a2 signifies that there was no increase in expression of this SLC in the presence of apoptotic cells, relative to the control condition. Data represent two replicates with 6 mice per group per experiment. c, Specific SLC signature during different stages of efferocytosis. RNA-seq was performed using mRNA from LR73 cells treated for 4 h with supernatants of apoptotic cells, or LR73 cells treated with cytochalasin D and incubated with apoptotic cells. SLC genes altered by supernatant alone (smell), and cytochalasin D-sensitive SLCs (ingestion) were used to identify SLCs responding to ligand-receptor interactions (taste) (red, upregulated; blue, downregulated). For clarity, SLCs in more than one stage are not shown. In all figures, *P < 0.05, **P < 0.01, ***P < 0.001. Letter reSeArCH binding of apoptotic targets or phosphatidylserine (PtdSer) liposomes to phagocytes (without internalization) was sufficient to induce Slc2a1 (Fig. 5b) . Masking PtdSer on targets (using BAI1-TSR, the PtdSerbinding domains of BAI1) reduced upregulation of Slc2a1 (but not that of Sgk1) during efferocytosis (Extended Data Fig. 8b) . Therefore, SGK1-triggered by factors released from apoptotic cells-prepares the phagocytes by increasing abundance of endogenous SLC2A1 on the plasma membrane, and PtdSer-dependent interactions increase new transcription and expression of SLC2A1.
Following corpse internalization in phagocytes, there was increased expression of Slc16a1, a plasma membrane proton-linked monocarboxylate transporter of lactate and pyruvate 18 (Figs. 1b, 2a-c, 5c, Extended Data Fig. 8b ). siRNA-mediated knockdown of Slc16a1 in LR73 cells reduced efferocytosis in vitro (Extended Data Fig. 8c) , and SR13800-a bioactive inhibitor of SLC16A1-reduced apoptotic cell uptake by peritoneal macrophages in vivo (Extended Data Fig. 8d ). Supernatants of engulfing LR73 cells contained threefold-higher lactate concentration (approximately 5 mM) compared to supernatants of phagocytes without apoptotic cells (approximately 1.5 mM) (Fig. 5d) . siRNA knockdown of Slc16a1 reduced lactate concentration in the supernatants to approximately 2 mM, with concomitant accumulation in phagocytes (Fig. 5d) , indicating that SLC16A1 contributes to lactate release from engulfing phagocytes.
Lactate released from solid tumours could act on naive macrophages to induce M2 macrophage-like polarization 3 . To test whether factors released via SLC16A1 during efferocytosis might also promote antiinflammatory skewing of naive macrophages 19 , we tested the effect of supernatants of engulfing LR73 phagocytes on BMDMs (Fig. 5e) . These supernatants induced upregulation of anti-inflammatory macrophage genes such as Tgfb1 and Il10 as well as anti-inflammatory or M2-like markers, including Vegfa, Mgl1, Mgl2 and CD206 (also known as Mrc1), physiological glucose (1 mg ml −1 ), black; high glucose (5 mg ml −1 ), orange. Glucose was added to medium simultaneously with apoptotic cells. Data from at least 3 independent experiments with 2-3 replicates per condition. Note that this differs from long-term glucose-free pretreatment of phagocytes 12 . b, Increased glucose uptake via SLC2A1 during efferocytosis. LR73 cells were co-cultured with apoptotic Jurkat cells for 2 h, washed and 2-DG uptake was measured. Data from 2 independent experiments with 3 replicates each. c, Increased glycolysis in phagocytes during apoptotic cell clearance. Glycolysis and OXPHOS were measured during efferocytosis (with Seahorse XF) using extracellular acidification rate (ECAR) and oxygen consumption rate (OCR). Data are mean ± s.d. of two replicates per condition from two independent experiments. d, Heat map showing upregulation of glycolysis-associated genes during efferocytosis. e-h, Effect of siRNA targeting of Pdk1 (e), Pdk4 (f) or Sgk1 (h), or dichloroacetate, a pan-PDK inhibitor (g), on efferocytosis in LR73 cells. Data represent three independent experiments with 3-4 replicates per condition. i, F-actin formation during efferocytosis. LR73 phagocytes were co-incubated with CFSE-labelled apoptotic thymocytes for 30 min, stained with phalloidin and actin polymerization was measured using by flow cytometry. PDK1 inhibitor experiments were performed separately. MFI, mean fluorescence intensity; rel., relative. Data represent at least 3 independent experiments with 3-4 replicates. Letter reSeArCH whereas pro-inflammatory markers (Tnf and Il6) were not affected. Slc16a1 knockdown attenuated this effect in engulfing LR73 cells (Fig. 5f, Extended Data Fig. 8e, f) . Therefore, aerobic glycolysis induced during efferocytosis affects efferocytosis at two levels: regulation of corpse uptake through regulation of actin polymerization (involving SLC2A1); and modulation of expression of anti-inflammatory genes in neighbouring cells (via SLC16A1).
The results presented here provide several key insights. Although the SLC family is the second largest among membrane proteins (after G-protein-coupled receptors), there is much less knowledge of SLC function in specific physiological contexts 6 . This work describes coordinated regulation of select SLCs during efferocytosis (Fig. 5g) . The smell, touch and ingestion phases of efferocytosis induce distinct and overlapping sets of SLC genes with functional consequences; these sets of genes are distinct from those that are activated during antibody-mediated phagocytosis. Efferocytosis induces a metabolic gene program promoting glucose uptake and subsequent glycolysis, with concurrent downregulation of genes linked to OXPHOS and FAO. Although efferocytic macrophages are more M2-like 20 , and M2-like macrophages are reported to be OXPHOS-dependent 21 , our study of the first few hours of efferocytosis does not rule out a role for OXPHOS at later times. Although glycolysis is linked to inflammation, efferocytic phagocytes can influence non-engulfing naive macrophages in the tissue microenvironment towards anti-inflammatory polarization by SLC16A1-mediated lactate release, as well as other factors 22 released during efferocytosis such as TGFβ and IL-10.
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MEthodS
The investigators were not blinded to allocation during experiments and outcome assessment. In vitro engulfment assay. For induction of apoptosis 22 , human Jurkat T cells resuspended in RPMI with 1% BSA were treated with 150 mJ/cm 2 ultraviolet C irradiation (Stratalinker) and incubated for 4 h at 37 °C with 5% CO 2 . For antibodydependent phagocytosis, Jurkat cells were labelled with CD3 antibody (25 µg/ml; clone OKT3, BioLegend) along with annexin V recombinant protein (to block efferocytosis of any residual dying cells) (3 µg/ml; eBioscience) for 1 h at 4 °C and the cells 23 were then stained with CypHer5E (GE Healthcare, PA15401) or TAMRA (Invitrogen, C-1171) before use in the engulfment assays. Chinese hamster LR73 cells or mouse macrophages were seeded in a 24-well plate and incubated with targets at a 1:10 phagocyte:target ratio for the indicated times. Targets were then washed with PBS. Where indicated, phagocytes were rested in culture medium for an additional period of time. Cells were dissociated from the plate with trypsin and the phagocytes were assessed by a flow cytometry-based assay or analysed for RNA or protein 24 . Phalloidin staining was conducted according to the manufacturer's instruction (Invitrogen). When primary macrophages were used as phagocytes, there was an inherent difference in the absolute percentage uptake of corpses between experiments performed on different days. Therefore, phagocytic index was used to better compile data from multiple experiments. All cell lines (except LR73 cells) were obtained from ATCC. LR73 cells were obtained from C. Stanners 23 . Cells we routinely tested for mycoplasma contamination and all cell lines tested negative. RNA sequencing. LR73 cells were co-cultured with apoptotic Jurkat cells for 2 h, unbound Jurkat cells were removed by washing with PBS and the phagocytes were rested in culture medium for an additional 2 h. Total RNA was extracted, and an mRNA library was prepared using the Illumina TruSeq platform, followed by sequencing using an Illumina NextSeq 500 cartridge. Four independent experiments were sequenced. R v.3.2.2 was used for graphical and statistical analysis and the R package DESeq2 was used for count normalization and differential gene expression analysis of RNA-seq data. All genes were curated using a combination of literature mining and function determination (known or predicted) via Uniprot. Genes involved in multiple associated functions (for example, kinases or cell-cycle-related) were excluded. We generated functional classifications of solute carrier (SLC) proteins on the basis of several criteria: (1) a known function was ascribed to the channel directly (for example, SLC2A1 is required for glycolysis); a known function was ascribed to the solute transported by the channel (for example, SLC2A1 transports glucose, glucose is required for glycolysis, therefore SLC2A1 is required for glycolysis); or by predictive homology (for example, SLC2A1 transports glucose and is required for glycolysis; as SLC2A4 is homologous to SLC2A1, SLC2A4 may therefore be important for glycolysis). Several SLCs have been shown or are predicted to perform multiple functions. These alternative functions are listed in Supplementary Table 3 . Network analysis was performed using the network analytical software Gephi v.0.9.1 (https://gephi.org/). Standard algorithms for calculating clusters were used as implemented in Gephi. The edges and community links were calculated using the 'link communities' plug-in based on the algorithms proposed for biological network analyses 25 . Network structure was determined using the Fruchterman-Reingold force-directed layout algorithm. All code used for analysis is available upon request. qRT-PCR. Total RNA was extracted from cells using the RNeasy Mini Kit (Qiagen) and cDNA was synthesized using QuantiTect Reverse Transcription Kit (Qiagen), according to the manufacturers' instructions. Quantitative gene expression analysis for hamster and mouse SLCs was performed using hamster-and mouse-sequence specific Taqman probes that are non-cross reactive with human sequences (Applied Biosystems), run on a StepOnePlus Real Time PCR System (Applied Biosystems). Details of Taqman primers are listed in Supplementary Information. In vivo engulfment assay and qRT-PCR. Six million apoptotic Jurkat cells, stained with CypHer5E, or as control X-VIVO 10 medium alone, were intraperitoneally injected (300 µl per mouse). At indicated times post-injection, mice were euthanized, and the peritoneal lavage was collected in 10 ml PBS + 10% fetal bovine serum (FBS). The collected cells were stained with CD11b PE-Cy7 (eBioscience, Cat#: 25-0112-82) and F4/80 APC-eFluor 780 (eBioscience, Cat#: 47-4801-80), and the uptake of the injected CypHer5E + apoptotic cells by CD11b In vivo thymus efferocytosis assay. Six-to eight-week-old mice were injected intraperioneally with 300 µl PBS containing 250 µg dexamethasone (Sigma) with or without STF-31 (10 mg/kg) dissolved in EtOH. Four hours after injection, thymi were collected from mice, and the numbers of thymocytes with annexin V staining only (apoptotic) versus annexin V, 7-aminoactinomycin D (7-AAD) doublepositive cells (secondarily necrotic) were determined by flow cytometry. In vivo bone marrow transplantation and analysis of necrotic cores in atherosclerosis. At six weeks of age, Ldlr −/− mice received two doses of X-ray irradiation (500 cGy × 2, 4 h apart; X-RAD), and were then transplanted with bone marrows isolated from Slc2a1 fl/fl or LysM-cre/Slc2a1 fl/fl donor mice. Control animals were transplanted with HBSS buffer only-these mice died within 10-11 days of lethal irradiation. Following bone marrow transplantation, chimeric Ldlr −/− mice were transferred to sterile cages with ad libitum access to sterile mouse chow and sterile water and were maintained on chow diet for four weeks before challenge with Western Diet (Harlan Teklad TD88137, 42% of Kcal from milk fat with 0.15% added cholesterol) for 12 weeks. Following mice dissection, hearts were isolated for formalin-fixed paraffin-embedded sections. The sections were stained with Masson's trichrome for quantification of necrotic core areas and normalized to total quantified area. Necrotic core size was measured using Aperio ePathology software (Aperio). TUNEL staining was conducted according to the manufacturer's instructions (Promega). In vivo phagocytosis analysis in zebrafish. To inhibit the expression of slc2a1, antisense morpholinos targeting the translational start site of the zebrafish slc2a1a (5′-GGCCATCATCAGCTGAGGAGTCACC-3′) were synthesized (Gene Tools). A control morpholino (5′ GGCCATCATCAGCTGAGGAGTCACC-3′) was used as anegative control. Morpholino (2.5 ng) was microinjected into Tg(mpeg1:GFP) embryos at the one-cell stage. Embryos were treated with phenylthiourea (0.004%) in egg water at 24 hpf to reduce pigmentation as per standard protocols. 8-10 h before imaging, embryos were soaked in 2.5 µg/ml neutral red (Sigma) in egg water. At 50 hpf, morphants were anaesthetized with 3-aminobenzoic acid ester (Tricaine), immersed in 0.8% low-melting-point agarose and mounted laterally in glass-bottomed 35-mm Petri dishes for confocal imaging. Three identical z-stack images were taken for each embryo covering hemi-segments of somites 6 to 20. More than 100 macrophages were counted per group for the evaluation of GFP and neutral red colocalization. CRISPR-Cas9 deletion or siRNA knockdown of SLCs. Stable, individual clones of Cas9-GFP-expressing LR73 cells were generated by lentiCas9-EGFP plasmid via lentiviral transduction and a protocol adapted from ref. 26 , followed by singlecell cloning of GFP-expressing cells and Cas9 expression verification. Slc2a1 was deleted from LR73 cells using two independent Cas9-GFP LR73 cell clones and using lentiGuide-Puro sgRNA plasmid with two unique guides for Slc2a1. LentiCas9-EGFP was a gift from P. Sharp and F. Zhang (Addgene plasmid # 63592) and lentiGuide-Puro was a gift from F. Zhang (Addgene plasmid # 52963).
Guide RNAs targeting Slc2a1 were generated using the following oligonucleotide pairs. Guide 1: 5′ CACCGATTCTTCCGGACATCATCGC-3′, 3′-CTAA GAAGGCCTGTAGTAGCGCAAA-5′; guide 2: 5′-CACCGTTCGGCC TGGACTCCATTA-3′, 3′-CAAGCCGGACCTGAGGTAATCAAA-5′.
For siRNA and plasmid transduction experiments, LR73 cells were treated with Lipofectamine 2000 (Thermo Fisher) with specific siRNAs, according to the manufacturer's instructions, 2 days before the engulfment assay. GLUT1-eGFP/ pcDNA-DEST47 was a gift from W. Frommer (Addgene plasmid #18729) 27 . siRNAs targeting hamster mRNAs were customized by GE Healthcare Dharmacon.
Primers for siRNA against Slc2a1: 5′-CCAAGAGUGUGCUGAAGAAUU-3′. Two siRNAs against Sgk1: 5′-CUUCUAUGCUGCUGAAAUAUU-3′, 5′-CU GCAGAAGGACAGGACAAUU-3′. Two siRNAs against Pdk1: 5′-CGA CAAGAGUUGCCUGUUAUU-3′, 5′-GGACAAAAGUGCUGAAGAUUU-3′. Two siRNAs against Pdk4: 5′-UCACACAAGUAAAUGGAAAUU-3′, 5′-CAUCAAAGUUCGAAACAGAUU-3′. siRNA against Slc16a1: 5′-AGAAA CAGGAAGAAGGUAAUU-3′. Macrophage isolation and analysis. To obtain BMDMs, femurs from control mice, mice carrying floxed alleles of Slc2a1, or Glut1-Myc knock-in mice were removed and flushed with 5 ml sterile PBS containing 5% FBS 28, 29 . The cell suspension was centrifuged, treated with red blood cell lysis buffer, washed and then plated onto sterile Petri dishes in DMEM containing 10% L929 medium, 10% FBS and 1% penicillin-streptomycin-glutamine. Medium was replenished every 2-3 days and differentiated cells were used at day 6 post-collection. To delete Slc2a1, macrophage cultures were treated with TAT-Cre (EMD Millipore), according to the manufacturer's instructions. For staining, BMDMs were stained with F4/80 APC-eFluor 780 (eBioscience, Cat#: 47-4801-80) and subsequently stained with Myc PerCP antibody (Novus Biologicals, 9E10 Cat#: NB600-302PCP) or fixed and permeabilized using FoxP3/Transcription Factor Staining Buffer Set (eBioscience), and intracellular staining was performed using CD206 PE (BioLegend, Cat#: 141706). Resident peritoneal macrophages were obtained by flushing the peritoneal cavity of mice with 10 ml cold PBS containing 5% FBS. Collected cells were spun down, resuspended in X-VIVO 10 (Lonza), and plated at a concentration of 5 × 10 5 cells per well. Floating cells were removed the next day, and remaining peritoneal macrophages were used 2 days after isolation.
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Glucose uptake assay. LR73 cells were incubated with apoptotic Jurkat cells for 2 h, washed 3 times with PBS and incubated with 10 mM 2-DG, a glucose analogue, in glucose-free medium for 30 min. Following incubation, cells were washed 3 times with PBS and lysed with Extraction Buffer (Sigma Cat#: MAK083). Lysate was frozen-thawed in dry ice/ethanol, and then heated at 85 °C for 40 min. Lysate was then cooled on ice for 5 min and then neutralized by Neutralization Buffer (Sigma Cat#: MAK083). Samples were spun down at 13,000g to remove insoluble fraction and then diluted tenfold by adding Assay Buffer (Sigma Cat#: MAK083). Using the lysate, glucose uptake was measured using Glucose Uptake Colorimetric Assay Kit (Sigma). 2-DG is taken up by cells and phosphorylated by hexokinase to 2-DG6P. 2-DG6P cannot be further metabolized and accumulates in cells, directly proportional to the glucose uptake by cells. 2-DG uptake is determined by a coupled enzymatic assay in which the 2-DG6P is oxidized, resulting in the generation of NADPH, which is then determined by a recycling amplification reaction in which the NADPH is used by glutathione reductase in a coupled enzymatic reaction that produces glutathione. Glutathione reacts with DTNB to produce TNB, which was detected at 412 nm as per the manufacturer's recommendations. Seahorse analysis. LR73 cells or BMDMs were seeded into a Seahorse 24-well tissue culture plate (Agilent Technologies). The cells adhered overnight before treatment. For assessing respiratory capacity, cells were subjected to a mitochondrial stress test. In brief, at the beginning of the assay, the medium was changed to DMEM containing pyruvate (Thermo Fisher Cat#:12800017, pH = 7.35 at 37 °C) and cells were allowed to equilibrate for 30 min. OCR was measured using a Seahorse XF24 Flux Analyzer (Agilent Technologies). After three basal OCR measurements, the drugs of interest were injected into the plate and OCR was measured using four-minute measurement periods. Compounds to modulate cellular respiratory function (1 µM oligomycin (Sigma-Aldrich); 2 µM BAM15 (Cayman Chemical Company); 1 µM antimycin A and 100 nM rotenone (SigmaAldrich)) were injected after every three measurements. Basal respiration was calculated by subtracting the average of the first three measurements by the average of the post-antimycin A and rotenone measurements. Maximum respiratory capacity was calculated by subtracting the average of the post-BAM15 measurements by the average of the post-antimycin A and rotenone measurements. The reserve capacity was calculated by subtracting the average of the basal measurements from the average of the post-BAM15 measurements.
For assessing glycolytic capacity, the cells were subjected to a glycolytic stress test. In brief, ECAR-a measurement of lactate export-was measured using a Seahorse XF24 Flux Analyzer. Cells were seeded into a Seahorse 24-well tissue culture plate. At the beginning of the assay, the medium was changed to unbuffered, glucose-free DMEM (Sigma-Aldrich Cat# D5030, pH 7.35 at 37 °C), supplemented with 143 mM NaCl and 2 mM glutamine. After three basal ECAR measurements, the drugs of interest were injected into the plate and ECAR was measured using 3-min measurement periods. Compounds to modulate glycolysis (20 mM glucose; 1 µM oligomycin; 80 mM 2-DG) (Sigma) were injected after every three measurements. Basal glycolysis was calculated by subtracting the average of the post-2-DG measurements from the average of the post-glucose measurements. Maximum glycolytic capacity was calculated by subtracting the average of the post-2-DG measurements from the average of the post-oligomycin measurements. The glycolytic reserve capacity was calculated by subtracting the average of the postoligomycin measurements from the average of the post-glucose measurements. Liposome construction. Liposomes were prepared by dissolving the lipids (phosphatidylserine, dioleoyl phosphatidylcholine, cholesterol and the lipid DiD dye) in chloroform, evaporating chloroform under flow of argon gas in a glass vial and subjecting the lipid layer to overnight lyophilization to remove traces of organic solvent. Normal saline was then added for hydration, and after vortexing was done to prepare multilamellar vesicles. Particle size was verified by dynamic light scattering using Nicomp 370. Determination of lactate concentration. The lactate concentration was measured using a Lactate Assay Kit (Sigma) according to the manufacturer's instructions.
The mean values ± s.d. of the lactate concentration in the medium and cells were calculated for each condition. Immunoblotting. LR73 cells were seeded in a 100-mm dish at a concentration of 2 million cells per dish. Apoptotic Jurkat cells were added as indicated. Cells were lysed in RIPA buffer and immunoblotted with SLC2A1 (Abcam #ab652), SLC16A1 (LSBio LS-C335287), SLC12A2 (Cell Signaling Technology #14581) and total Erk2 (Santa Cruz Biotechnology, #sc-154-G) antibodies in Can Get Signal solution (TOYOBO Cat# NKB-101) followed by chemiluminescence detection. Specific bands were quantified using Adobe Photoshop CS6. Research animals. Power of 80% was used to determine the number of mice needed to achieve a two-sided 5% significance level to detect a twofold change for each set of in vivo studies. Allocation of mice was random in all in vivo experiments. Mice were taken from littermates. Animal breeding and experiments were performed in a specific pathogen-free animal facility using protocols approved by th University of Virginia Animal Studies Committee. Ethical guidelines determined by the Institutional Animal Care and Use Committee were followed in all experiments performed in this manuscript. Statistical analysis. Statistical significance was determined using GraphPad Prism 7, using unpaired Student's two-tailed t-test, one-way ANOVA or two-way ANOVA, according to test requirements. Grubbs' outlier test was used to determine outliers, which were excluded from final analysis. *P < 0.05, **P < 0.01, ***P < 0.001 were considered significant. Number of replicates and repeats of individual experiments and statistical tests used are shown in Supplementary Table 4 . Code availability. All code used in this manuscript can be accessed from the Github repository https://github.com/perryjs/Perry-R. Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. 
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